Interleukin-8: A critical chemokine in biliary atresia

J Gastroenterol Hepatol. 2015 Jun;30(6):970-6. doi: 10.1111/jgh.12900.

Abstract

Biliary atresia (BA) is characterized by periductular inflammation and fibrosis and is associated with the progressive obliteration of the bile ducts. The induction and maintenance of systemic and local inflammatory responses plays a pivotal role in this process. Interleukin-8 (IL-8) is an important mediator of inflammation and the immune response in human disease. IL-8 is overexpressed in BA, and its expression positively correlates with inflammation and liver fibrosis. In this review, we focus on the available evidence, recent insights, and future clinical and preclinical possibilities regarding the role of IL-8 in BA.

Keywords: biliary atresia; inflammation; interleukin-8; liver fibrosis; signaling.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biliary Atresia / diagnosis
  • Biliary Atresia / drug therapy
  • Biliary Atresia / etiology*
  • Biliary Atresia / immunology
  • Biomarkers / metabolism
  • Humans
  • Inflammation Mediators* / metabolism
  • Inflammation Mediators* / physiology
  • Interleukin-8 / immunology*
  • Liver Cirrhosis
  • Molecular Targeted Therapy

Substances

  • Biomarkers
  • CXCL8 protein, human
  • Inflammation Mediators
  • Interleukin-8